Parkinson’s disease: When molecular guardians need to be protected

Parkinson’s disease is the second most common, age-related, neurodegenerative disease: In Germany alone, about 300,000 people are affected and experience sometimes major limitations to their quality of life. Although Parkinson’s is so widespread, there is still no treatment that targets the cause of the disease and can stop it in its tracks. However, current research […]

Continue Reading

Virtual reality could help to reduce pain for people with nerve injuries

We all feel physical pain in different ways, but people with nerve injuries often have a dysfunctional pain suppression system, making them particularly prone to discomfort. Now researchers have uncovered that virtual reality (VR) can reduce types of pain typically seen in patients with nerve injuries—and that VR can boost the dysfunctional pain suppression system, […]

Continue Reading

Study: Older multiple myeloma patients can be spared of long-term steroids

The combination of cancer therapy lenalidomide plus the steroid dexamethasone (together called Rd) is considered standard treatment for elderly patients with multiple myeloma. However, prolonged steroid use can be harmful for some older adults. A new study published in Blood found that switching select older patients to a lower dose of lenalidomide and discontinuing dexamethasone […]

Continue Reading